Fabtech Technologies secured consolidated orders worth ₹33.79 crore in June 2026, led by demand from the Pharma and Renewable Energy sectors. The company's consolidated order book stands at ₹362.41 crore as of June 30, 2026, providing visibility for future revenue. Orders under active consideration have risen significantly to ₹514.78 crore, indicating strong potential for further growth.

The order intake for June 2026 was led by the Pharma sector, which contributed ₹20.36 crore, followed by Others at ₹8.98 crore and Renewable Energy at ₹4.45 crore. From a business vertical perspective, HVAC Systems accounted for ₹17.81 crore, while Cleanroom Partitions contributed ₹15.98 crore.

Order Book Position

As of June 30, 2026, the consolidated order book of ₹362.41 crore is diversified across high-growth sectors. Renewable Energy constitutes the largest portion at ₹177.63 crore, followed by Pharma at ₹147.40 crore. Data Centres account for ₹26.74 crore, while Semiconductors and Others contribute ₹0.50 crore and ₹10.14 crore respectively.

Pipeline and Strategic Focus

Fabtech Cleanrooms Ltd has orders worth ₹514.78 crore under active consideration. Major opportunities lie in Renewable Energy with ₹269.00 crore, Pharma with ₹229.01 crore, and Data Centres with ₹12.00 crore. The company continues to strengthen its presence in sectors such as Renewable Energy, Pharmaceuticals, Data Centers, Semiconductors, and Nutraceuticals. This strategic diversification reflects its capability to deliver integrated cleanroom and HVAC solutions for complex manufacturing environments. The Others category includes Commercial, FMCG, and miscellaneous industries.

Fabtech Cleanrooms Limited held an analyst and investor meeting in Mumbai on June 25, 2026, as part of The Growth Exchange 2026 – Niveshak Samvad Roadshow. The session took place from 4:00 p.m. to 5:00 p.m. IST. The company confirmed that the discussion was based on publicly available information and no unpublished price-sensitive information was shared.

The disclosure was made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Amjad Adam Arbani, Executive Director, signed the disclosure on behalf of the company.

Financial Performance

The investor presentation for the roadshow highlights a consolidated order book of ₹354.74 crore as of May 31, 2026. The company reported a total income of ₹221.72 crore, EBITDA of ₹23.16 crore, and a Profit After Tax (PAT) of ₹15.82 crore for the consolidated entity. On a standalone basis, the entity reported a total income of ₹143.39 crore, an EBITDA of ₹12.96 crore, and a PAT of ₹9.06 crore.

Order Book and Sectoral Breakdown

The total order booking position of ₹354.74 crore is driven primarily by the Renewable Energy and Pharma sectors. The Renewable Energy Sector accounts for ₹184.42 crore, followed by the Pharma Sector at ₹135.18 crore. Data Centers contribute ₹27.17 crore, while the SemiConductor sector and others account for ₹0.5 crore and ₹7.47 crore, respectively.

Strategic Subsidiaries and Market Outlook

Fabtech's growth strategy is anchored in its subsidiaries Kelvin, Advantek, and AART Integrated Projects Pvt. Ltd. The presentation projects significant market growth by 2030, estimating the Data Center market at $21B, the Solar Market at $24–25B, Life Sciences at $13B, and the Semiconductor Market at approximately $110B.